COELIAC DISEASE
Eurospital propose a range of products for identification of patients genetically predisposed to coeliac disease by detecting the following parameters:
- Genotype
- Risk
- Prevention
It does refer to two different PCR methods, developed and made available by Eurospital R&D. Both technologies identify the main HLA Genotypes predisposing to the development of Coeliac Disease.
| Eu-Gen System End-point PCR method on Agarose gel.  | XeliGen-RT Real Time PCR method. |
Eurospital also proposes a complete panel of products for the in-vitro diagnosis of coeliac disease.
>> Go to Coeliac Disease page
>> Go to Coeliac Disease page
